Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,969 | 15,532 | 8,046 | 7,831 | -913 |
| Depreciation Amortization | 5,863 | 18,031 | 13,476 | 8,966 | 4,415 |
| Income taxes - deferred | 122 | 1,980 | N/A | N/A | N/A |
| Accounts receivable | -3,429 | -8,770 | -11,510 | -6,485 | 2,942 |
| Accounts payable and accrued liabilities | -1,390 | 3,260 | 5,261 | 2,671 | -1,186 |
| Other Working Capital | -11,827 | -34,082 | -22,802 | -14,240 | -5,898 |
| Other Operating Activity | 8,553 | 28,908 | 24,588 | 12,863 | 2,051 |
| Operating Cash Flow | $-5,077 | $24,859 | $17,059 | $11,606 | $1,411 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,562 | -33,898 | -23,242 | -12,840 | -6,672 |
| Investing Cash Flow | $-7,562 | $-33,898 | $-23,242 | $-12,840 | $-6,672 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -938 | -3,013 | -1,138 | -1,138 | -568 |
| Common Stock Issued | N/A | 2,070 | 2,070 | 2,042 | 291 |
| Other Financing Activity | -298 | -1,256 | -1,256 | -1,254 | -488 |
| Financing Cash Flow | $-1,236 | $-2,199 | $-324 | $-350 | $-765 |
| Beginning Cash Position | 103,290 | 114,528 | 114,528 | 114,528 | 114,528 |
| End Cash Position | 89,415 | 103,290 | 108,021 | 112,944 | 108,502 |
| Net Cash Flow | $-13,875 | $-11,238 | $-6,507 | $-1,584 | $-6,026 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,077 | 24,859 | 17,059 | 11,606 | 1,411 |
| Capital Expenditure | -7,562 | -33,898 | -23,242 | -12,840 | -6,672 |
| Free Cash Flow | -12,639 | -9,039 | -6,183 | -1,234 | -5,261 |